Exclusive Research Partnership to Bring MR Fingerprinting to Clinical Application Stage

The MR Fingerprinting (MRF) software package has already been evaluated successfully by several research facilities.

The partnership between Siemens Healthcare (Erlangen, Germany) and Case Western Reserve University (CWRU; Cleveland, OH, USA) was announced in Singapore at the Annual Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM).

MRF provides a non-invasive quantification of tissue properties and can be used to measure multiple parameters simultaneously. The technique provides a unique fingerprint for each type of tissue, disease, or material in the body. MRF can provide a low level of variance across many exam types, different MR scanners, and institutions, and could help clinicians monitor and evaluate patient treatments with greater accuracy.

MRF has previously been used for cardiac examinations and for multiple sclerosis patients. The CWRU research team has successfully used the technique for patients with brain tumors, prostate tumors, and breast cancer patients with liver metastases.

Prof. Siegfried Trattnig from the Medical University of Vienna, who has done initial research with brain tumor and glioma patients, said, "The MR Fingerprint technique lets us see more details than the standard imaging process, and has the potential to redefine MRI. In this way, MRF could help us, as radiologists, to make the paradigm shift from qualitative to quantitative imaging and to incorporate quantitative data into our daily routine."

Related Links:
Siemens Healthcare
Case Western Reserve University